A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection.

A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection.

Latent Epstein-Barr virus (EBV) infection contributes to both B-cell and epithelial-cell malignancies. However, whether lytic EBV infection also contributes to tumors is unclear, although the association between malaria infection and Burkitt lymphomas (BLs) may involve excessive lytic EBV replicatio...

Full description

Bibliographic Details
Main Authors: Jillian A Bristol, Reza Djavadian, Emily R Albright, Carrie B Coleman, Makoto Ohashi, Mitchell Hayes, James C Romero-Masters, Elizabeth A Barlow, Paul J Farrell, Rosemary Rochford, Robert F Kalejta, Eric C Johannsen, Shannon C Kenney
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-07-01
Series:PLoS Pathogens
Online Access:http://europepmc.org/articles/PMC6082571?pdf=render

Internet

http://europepmc.org/articles/PMC6082571?pdf=render

Similar Items